FAA Proposes Diabetes Rule for Pilot Certification
New proposal would allow pilots using non-insulin diabetes medication to receive medical certificates more quickly.
Updated on Oct. 22, 2026 in Diabetes
Live Poll
Should the FAA simplify medical certification requirements to reduce pilot application backlogs?
The FAA has proposed a new rule that would allow aviation medical examiners to issue medical certificates to pilots who use non-insulin diabetes medication. This change aims to simplify the certification process and address ongoing application backlogs.
Why it matters
The proposal intends to streamline the medical certification process for thousands of pilots while reducing the heavy backlog facing the agency. By shifting authority to examiners, the FAA seeks to make essential health clearances more efficient for the aviation workforce.
Approximately 3,000 applicants annually could qualify for immediate certification under the new rule. The agency also increased its medical officer staff from 52 to 78 to improve processing times.
The players
Federal Aviation Administration
The national aviation authority responsible for the regulation of civil aviation and the health certification of pilots.
The details
The FAA is expanding the authority of aviation medical examiners to handle certain mental health renewals and process cases for diabetes management. Pilots who rely on insulin for their condition must continue to follow the existing Special Issuance process rather than the proposed expedited path.
Timeline
May 2026: The U.S. Office of Special Counsel released a report on application backlogs.
July 2026: The FAA expanded aviation medical examiner authority regarding mental health.
September 2026: The diabetes rule proposal was first introduced.
October 21, 2026: FAA officials discussed these regulatory efforts at the NBAA-BACE panel in Las Vegas.
Health Landscape
This proposal marks a significant departure from the traditional FAA Special Issuance process, which currently governs pilot medical certification for chronic conditions. It indicates a broader effort to modernize medical oversight by reducing bureaucratic friction.
Pilots using non-insulin diabetes medication may soon face a less burdensome path to obtaining their medical certificates. Those requiring insulin treatment should note that their specific medical certification requirements remain unchanged by this proposal.
The takeaway
The FAA is prioritizing efficiency by delegating more medical evaluation authority to examiners rather than centralizing all reviews. Pilots should monitor upcoming regulatory announcements to determine if their specific treatment plan qualifies for these streamlined procedures.
Further reading
Learn more about the latest regulatory shifts in United States Diabetes.
Source note: This article includes information reported by AVweb.
Live Poll
Should the FAA simplify medical certification requirements to reduce pilot application backlogs?
